Evidence map›Paper›PMID 27092072›Full record

ArticleFrontiers in neuroinformatics2016

Gene Prioritization for Imaging Genetics Studies Using Gene Ontology and a Stratified False Discovery Rate Approach.

Sejal Patel, Min Tae M Park, Alzheimer's Disease Neuroimaging Initiative, M Mallar Chakravarty, Jo Knight

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroinformatics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Brain Imaging Genomics: Integrated Analysis and Machine Learning.Proceedings of the IEEE. Institute of Electrical and Electronics Engineers · 2020
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Sejal PatelCampbell Family Mental Health Research Institute, Centre for Addiction and Mental HealthToronto, ON, Canada; Institute of Medical Science, Faculty of Medicine, University of TorontoToronto, ON, Canada.
Min Tae M ParkCerebral Imaging Centre, Douglas Mental Health University Institute, McGill UniversityVerdun, QC, Canada; Schulich School of Medicine and Dentistry, Western UniversityLondon, ON, Canada.
Alzheimer's Disease Neuroimaging Initiative
M Mallar ChakravartyCerebral Imaging Centre, Douglas Mental Health University Institute, McGill UniversityVerdun, QC, Canada; Department of Psychiatry, McGill UniversityMontreal, QC, Canada.
Jo KnightCampbell Family Mental Health Research Institute, Centre for Addiction and Mental HealthToronto, ON, Canada; Institute of Medical Science, Faculty of Medicine, University of TorontoToronto, ON, Canada; Department of Psychiatry, University of TorontoToronto, ON, Canada; Biostatistics Division, Dalla Lana School of Public Health, University of TorontoToronto, ON, Canada; Lancaster Medical School and Data Science Institute, Lancaster UniversityLancaster, UK.
Centre for Addiction and Mental Health · CAMcGill University · CAWestern University · CA

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

Imaging genetics is an emerging field in which the association between genes and neuroimaging-based quantitative phenotypes are used to explore the functional role of genes in neuroanatomy and neurophysiology in the context of healthy function and neuropsychiatric disorders. The main obstacle for researchers in the field is the high dimensionality of the data in both the imaging phenotypes and the genetic variants commonly typed. In this article, we develop a novel method that utilizes Gene Ontology, an online database, to select and prioritize certain genes, employing a stratified false discovery rate (sFDR) approach to investigate their associations with imaging phenotypes. sFDR has the potential to increase power in genome wide association studies (GWAS), and is quickly gaining traction as a method for multiple testing correction. Our novel approach addresses both the pressing need in genetic research to move beyond candidate gene studies, while not being overburdened with a loss of power due to multiple testing. As an example of our methodology, we perform a GWAS of hippocampal volume using both the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA2) and the Alzheimer's Disease Neuroimaging Initiative datasets. The analysis of ENIGMA2 data yielded a set of SNPs with sFDR values between 10 and 20%. Our approach demonstrates a potential method to prioritize genes based on biological systems impaired in a disease.

Indexed as

Alzheimer's disease (AD)gene ontology networkgenome wide association study (GWAS)imaging geneticsmagnetic resonance imaging (MRI)stratified false discovery rate (sFDR)

Identifiers

PMID27092072
PMCPMC4823264
OpenAlexW2324657934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.